The price of Aurora Cannabis Inc. (NASDAQ:ACB) shares last traded on Wall Street fell -1.94% to $0.48.
Based on available information, 8 analysts follow Aurora Cannabis Inc. (NASDAQ:ACB). The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $1.12 and a low of $0.51, we find $0.67. Given the previous closing price of $0.49, this indicates a potential upside of 36.73 percent. ACB stock price is now -10.87% away from the 50-day moving average and -39.25% away from the 200-day moving average. The market capitalization of the company currently stands at $248.28M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
Among analysts, 8 rate the stock a hold while 0 rate it a buy. Brokers who have rated the stock have averaged $0.74 as their price target over the next twelve months.
Insiders disposed of 24,206 shares of company stock worth roughly $11618.88 over the past 1 year. A total of 0.11% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in ACB stock. A new stake in Aurora Cannabis Inc. shares was purchased by ETF MANAGERS GROUP, LLC during the first quarter worth $4,006,000. PINZ CAPITAL MANAGEMENT, LP invested $287,000 in shares of ACB during the first quarter. In the first quarter, SIG NORTH TRADING, ULC acquired a new stake in Aurora Cannabis Inc. valued at approximately $119,000. GALLAGHER BENEFIT SERVICES, INC. acquired a new stake in ACB for approximately $22,000. FLOW TRADERS U.S. LLC purchased a new stake in ACB valued at around $17,000 in the second quarter. In total, there are 270 active investors with 12.49% ownership of the company’s stock.
A candlestick chart of Aurora Cannabis Inc. (NASDAQ: ACB) showed a price of $0.4893 on Wednesday morning. During the past 12 months, Aurora Cannabis Inc. has had a low of $0.48 and a high of $1.73. As of last week, the company has a debt-to-equity ratio of 0.33, a current ratio of 2.30, and a quick ratio of 1.60. The fifty day moving average price for ACB is $0.5370 and a two-hundred day moving average price translates $0.7857 for the stock.
The latest earnings results from Aurora Cannabis Inc. (NASDAQ: ACB) was released for Jun, 2023. The net profit margin was -90.30% and return on equity was -43.50% for ACB. The company reported revenue of $55.87 million for the quarter, compared to $39.82 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 40.29 percent.
Aurora Cannabis Inc.(ACB) Company Profile
Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company’s adult-use brand portfolio includes Aurora Drift, San Rafael ’71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Leduc, Canada.
